Skip to content

ACN - 101321555 | ABN - 39101321555

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

AHRECS icon
  • Home
  • About Us
    • Consultants
    • Services
  • Previous Projects
  • Blog
  • Resources
  • Feeds
  • Contact Us
  • More
    • Request a Quote
    • Susbcribe to REM
    • Subscribe to VIP
Menu
  • Home
  • About Us
    • Consultants
    • Services
  • Previous Projects
  • Blog
  • Resources
  • Feeds
  • Contact Us
  • More
    • Request a Quote
    • Susbcribe to REM
    • Subscribe to VIP
Exclude terms...
Aboriginal and Torres Strait Islander
AHRECS
Analysis
Artificial Intelligence
Arts
Australia
Authorship
Belief
Beneficence
Big data
Biobank
Bioethics
Biomedical
Biospecimens
Breaches
Cartoon/Funny
Case studies
Clinical trial
Collaborative research
Conflicts of interest
Consent
Controversy/Scandal
Controversy/Scandal
Creative
Culture
Data management
Database
Dual-use
Essential Reading
Ethical review
Ethnography
Evaluative practice/quality assurance
First People
Fraud
Gender
Genetics
Good practice
Guidance
Honesty
HREC
Human research ethics
Humanities
Institutional responsibilities
International
Journal
Justice
Links
Media
Medical research
Merit and integrity
Methodology
Monitoring
New Zealand
News
Online research
Peer review
Performance
Primary materials
Principles
Privacy
Protection for participants
Psychology
Publication ethics
Questionable Publishers
Research ethics committees
Research integrity
Research Misconduct
Research results
Researcher responsibilities
Resources
Respect for persons
Sample paperwork
sd
Serious Adverse Event
Social Science
SoTL
Standards
Supervision
Training
Vulnerability
Young people
Exclude news

Sort by

Human Research Ethics Research Integrity

I Was Wrong: We Can’t Skip Phase 3 Vaccine Trials – Forbes (Steven Salzberg | August 2020)

Posted by saviorteam in Human Research Ethics on August 23, 2020
Keywords: Beneficence, Bioethics, Biomedical, Clinical trial, Good practice, Medical research, Merit and integrity, News, Protection for participants, Research ethics committees, Researcher responsibilities
A 3d figure about to be crushed under a large red dice with the word 'LOSE' on every face

I wrote a blog post over the weekend that has generated tremendous pushback, including an op-ed in the New York Times as well as thousands of comments on Twitter.

This is a great story, which exemplifies that science constantly correct itself in light of new evidence.

In my previous post, I suggested that while we’re pursuing Phase 3 testing of several promising Covid-19 vaccines, we could simultaneously offer those same, unapproved vaccines to a wider community of volunteers, as long as those volunteers were fully informed. The benefits of moving quickly, I argued, would outweigh the risks.
.

I was wrong. After reading many of the responses to my article, some of them outlining the risks in greater detail, I have concluded that (1) the risks are greater than I presented them, and (2) the benefits are not as great as I had thought.

Read the rest of this discussion piece

Related Reading

No related Resources found

Related Links

Complaints against Research Ethics Monthly

Request a Takedown

Submission Guidelines

About the Research Ethics Monthly

About subscribing to the Research Ethics Monthly

A diverse group discussing a topic

Random selected image from the AHRECS library. These were all purchased from iStockPhoto. These are images we use in our workshops and Dr Allen used in the GUREM.

Research Ethics Monthly Receive copies of the Research Ethics Monthly directly
by email. We will never spam you.

  • Home
  • Services
  • About Us
  • Contact Us
Menu
  • Home
  • Services
  • About Us
  • Contact Us
  • Company
  • Terms Of Use
  • Copyright
  • Privacy Policy
  • Disclaimer
Menu
  • Company
  • Terms Of Use
  • Copyright
  • Privacy Policy
  • Disclaimer
  • Support
  • Contact Us
  • Site Map
Menu
  • Support
  • Contact Us
  • Site Map

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Facebook-f
Twitter
Linkedin-in